• Bole Sandesh S.
• Damal Akanksha Mohiniraj
• khose Chhaya bharat
• Garkal Aniket Balasheb

Dengue fever is acute febrile diseases, it’s caused by one of four closely related virus serotypes of the genusare Flavivirus, family Flaviviridae. Each serotype is sufficiently different that there is no cross-protection and epidemics caused by multiple serotypes can occurs. It’s transmitted to humans by the mosquito. The incidence of dengue has grown around the world in recent a period of ten years. However, several classes of agents are in under investigation as potential anti-dengue drugs, including direct host modulators, antivirals, and RNAi therapeutics. These anti-dengue drugs in development will be reviewed here. .

Keywords: Dengue viruses, Aedes mosquito, Ae. aegypti, Ae. Albopictus

"Emerging Therapies of Dengue", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 2, page no.f672-f692, February-2023, Available :http://www.jetir.org/papers/JETIR2302576.pdf

"Emerging Therapies of Dengue", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 2, page no. ppf672-f692, February-2023, Available at : http://www.jetir.org/papers/JETIR2302576.pdf